A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions

被引:30
|
作者
Cochran, JR [1 ]
Stern, LJ [1 ]
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
来源
CHEMISTRY & BIOLOGY | 2000年 / 7卷 / 09期
关键词
major histocompatibility complex; multivalent binding; oligomer; signal transduction; T-lymphocyte;
D O I
10.1016/S1074-5521(00)00019-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: T-cells are activated by engagement of their clonotypic cell surface receptors with peptide complexes of major histocompatibility complex (MHC) proteins, in a poorly understood process that involves receptor clustering on the membrane surface. Few tools are available to study the molecular mechanisms responsible for initiation of activation processes in T-cells. Results: A topologically diverse set of oligomers of the human MHC protein HLA-DR1, varying in size from dimers to tetramers, was produced by varying the location of an introduced cysteine residue and the number and spacing of sulfhydryl-reactive groups carried on novel and commercially available crosslinking reagents. Fluorescent probes incorporated into the cross-linking reagents facilitated measurement of oligomer binding to the T-cell surface. Oligomeric MHC-peptide complexes, including a variety of MHC dimers, trimers and tetramers, bound to T-cells and initiated T-cell activation processes in an antigen specific manner. Conclusion: T-cell receptor dimerization on the cell surface is sufficient to initiate intracellular signaling processes, as a variety of MHC-peptide dimers differing in intramolecular spacing and orientation were each able to trigger early T-cell activation events. The relative binding affinities within a homologous series of MHC-peptide oligomers suggest that T-cell receptors may rearrange in the plane of the membrane concurrent with oligomer binding.
引用
收藏
页码:683 / 696
页数:14
相关论文
共 50 条
  • [41] Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy
    Lorenz, Felix K. M.
    Ellinger, Christian
    Kieback, Elisa
    Wilde, Susanne
    Lietz, Maria
    Schendel, Dolores J.
    Uckert, Wolfgang
    HUMAN GENE THERAPY, 2017, 28 (12) : 1158 - 1168
  • [42] MHC class II T-cell receptor interactions potentiate secretion of IgG but not IgM in response to T-dependent antigens
    Takahashi, Y
    Ametani, A
    Totsuka, M
    Fujine, K
    Tsuji, NM
    Kurisaki, J
    Kaminogawa, S
    IMMUNOLOGY LETTERS, 1998, 61 (2-3) : 97 - 101
  • [43] CD8 Binding of MHC-Peptide Complexes in cis or trans Regulates CD8+ T-cell Responses
    Liu, Yang
    Cuendet, Michel A.
    Goffin, Laurence
    Sachl, Radek
    Cebecauer, Marek
    Cariolato, Luca
    Guillaume, Philippe
    Reichenbach, Patrick
    Irving, Melita
    Coukos, George
    Luescher, Immanuel F.
    JOURNAL OF MOLECULAR BIOLOGY, 2019, 431 (24) : 4941 - 4958
  • [44] MODEL FOR THE INTERACTION OF T-CELL RECEPTORS WITH PEPTIDE/MHC COMPLEXES
    BJORKMAN, PJ
    DAVIS, MM
    IMMUNOLOGICAL RECOGNITION, PTS 1 AND 2, 1989, 54 : 365 - 373
  • [45] MODEL FOR THE INTERACTION OF T-CELL RECEPTORS WITH PEPTIDE MHC COMPLEXES
    BJORKMAN, PJ
    DAVIS, MM
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1989, 54 : 365 - 373
  • [46] IAT EPITOPES ON T-CELL RECEPTOR FOR SELF MHC CLASS-II DETERMINANTS
    URACZ, W
    FOLIA BIOLOGICA, 1988, 34 (06) : 356 - 371
  • [47] The structural interactions between T cell receptors and MHC-peptide complexes place physical limits on self-nonself discrimination
    Wucherpfennig, KW
    MOLECULAR MIMICRY: INFECTION-INDUCING AUTOIMMUNE DISEASE, 2005, 296 : 19 - 37
  • [48] THE ROLE OF ENDOGENOUS ANTIGENIC PEPTIDE IN CLASS-II MHC ALLOREACTIVE T-CELL RESPONSE
    GORSKI, J
    ECKELS, DD
    HUMAN IMMUNOLOGY, 1988, 23 (02) : 102 - 103
  • [49] Characterization of transport of newly assembled, T cell-stimulatory MHC class II peptide complexes from MHC class II compartments to the cell surface
    Pond, L
    Watts, C
    JOURNAL OF IMMUNOLOGY, 1997, 159 (02): : 543 - 553
  • [50] A new paradigm for targeting gene delivery: Exploiting T-cell receptor and MHC/peptide interactions
    Peng, KW
    Holler, PD
    Orr, B
    Kranz, DM
    Russell, SJ
    MOLECULAR THERAPY, 2003, 7 (05) : S25 - S25